Safety Rates Drug Report: adverse events in 2014 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
103817241	10381724	1	I	2013	20140805	20140813	20140813	EXP		US-JNJFOC-20140804539	JANSSEN		0.00		A	M	Y	0.00000		20140813	N	CN	US	US

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	RECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM
103817241	10381724	1	PS	INVOKANA	CANAGLIFLOZIN	1	ORAL	TAKING AT LUNCHTIME	N	UNKNOWN	0	100	MG	TABLET
103817241	10381724	2	SS	INVOKANA	CANAGLIFLOZIN	1	ORAL	TAKING AT LUNCHTIME	N	UNKNOWN	204042	100	MG	TABLET
103817241	10381724	3	C	HUMAN INSULIN	INSULIN HUMAN	1			D		0

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
103817241	10381724	1	Type 2 diabetes mellitus
103817241	10381724	2	Type 1 diabetes mellitus
103817241	10381724	3	Diabetes mellitus

Outcome of event

Event ID	CASEID	OUTC COD
103817241	10381724	OT

Reactions reported

Event ID	CASEID	PT
103817241	10381724	Blood glucose decreased
103817241	10381724	Coma
103817241	10381724	Inappropriate schedule of drug administration
103817241	10381724	Off label use

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT	DUR	DUR COD
103817241	10381724	1	2013		0
103817241	10381724	2	2013		0